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Abstract 
Our aim was to systematically review the prevalence of Body Dysmorphic Disorder 
(BDD) in a variety of settings. Weighted prevalence estimate and 95% confidence intervals in 
each study were calculated. The weighted prevalence of BDD in adults in the community was 
estimated to be 1.9%; in adolescents 2.2%; in student populations 3.3%; in adult psychiatric 
inpatients 7.4%; in adolescent psychiatric inpatients 7.4%; in adult psychiatric outpatients 5.8%; 
in general cosmetic surgery 13.2%; in rhinoplasty surgery 20.1%; in orthognathic surgery 11.2%; 
in orthodontics/cosmetic dentistry settings 5.2%; in dermatology outpatients 11.3%; in cosmetic 
dermatology outpatients 9.2%; and in acne dermatology clinics 11.1%. Women outnumbered 
men in the majority of settings but not in cosmetic or dermatological settings. BDD is common 
in some psychiatric and cosmetic settings but is poorly identified.  
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Prevalence of body dysmorphic disorder in different settings: A systematic review 
 
Body dysmorphic disorder (BDD) consists of a preoccupation with a perceived defect. 
The ‘defect(s)’ is not noticeable to other people (or is minimal); however, it is associated with 
shame, depression, and a poor quality of life. BDD can be a chronic disorder, which persists for 
many years if left untreated, with surveys at specialist centres concluding high rates of 
psychiatric hospitalisation, suicidal ideation, and completed suicide (Phillips, Coles, et al., 2005; 
Phillips & Menard, 2006; Veale, Boocock, et al., 1996).  
Many resources are wasted on those with BDD who attend dermatological or cosmetic 
surgery settings in an attempt to “fix” their imagined defect and receive physical treatments 
instead of the psychiatric help they actually need (Phillips, Dufresne, Wilkel, & Vittorio, 2000; 
Sarwer, Pertschuk, Wadden, & Whitaker, 1998). Such patients are often dissatisfied with their 
cosmetic procedure and symptoms of BDD persist.  However, BDD appears to be relatively 
uncommon as a presenting problem in psychiatric services or it is poorly identified (Veale, 
Akyüz, and Hodsoll (2015). This may be because of stigma so that it presents in psychiatric 
services because of comorbidity (for example depression). Knowledge of the most common co-
morbid presentations may assist in identifying BDD. The reported sex ratio also appears to differ 
widely. Thus the sex ratio is reported as equal in a specialist BDD service (Phillips & Menard, 
2006) compared to a ratio of 2.58 female to male in the community (Schieber, Kollei, de Zwaan 
& Marti (2015). Therefore, knowledge of the epidemiology of BDD would be important for 
public health in order to identify settings in which it would be necessary to screen for BDD, the 
most appropriate screening measures, the most common co-morbid diagnoses and the sex ratio.  
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Screening for possible symptoms of BDD was never included in the early large 
catchment area surveys of psychiatric morbidity (Kessler et al., 1994; Singleton, Bumpstead, 
O'Brien, Lee, & Meltzer, 2001; Wells, Bushnell, Hornblow, Joyce, & Oakley-Browne, 1989). 
However, despite the fact that BDD was not identified in epidemiological surveys of psychiatric 
morbidity, a number of prevalence studies have since been conducted. These prevalence studies 
investigate BDD in a range of settings; however prevalence rates and sex ratios within each 
setting appear to vary widely. This has created a confused overall picture of how common or rare 
BDD actually is. The aim of this systematic review was therefore to determine (a) the weighted 
prevalence rate of BDD in different settings, (b) the type of screening question or questionnaire 
used for identifying BDD, (c) comorbidity through which it may present in psychiatric services, 
and (d) the sex ratio in different settings.  
 
    Method 
Eligibility Criteria 
Studies were included if two of the authors agreed on the following criteria: (a) BDD was 
diagnosed or screened using a validated measure or interview; (b) an estimated prevalence and a 
total number of the population affected was provided; and (c) the study was published in the 
English language. Studies were excluded if: (a) they were published in a language other than 
English; (b) BDD prevalence was not provided; (c) they were a systematic or literature review; 
(d) they were a case study; or (e) they were a comorbidity study.  
Information Sources 
Ovid Medline, Embase and PsychINFO were used to obtain separate literature searches 
up to June 2015. The results from the three databases were subsequently collated and duplicates 
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removed. In addition, the authors inspected the reference sections of relevant papers retrieved 
through the database search.  
Search 
The search strategy was: (a) epidemiology OR epidemiologic studies OR incidence OR 
prevalence OR occur* OR frequenc* OR proportion* OR rate* OR number* OR percent*; (b) 
body dysmorphic disorder.sh. OR body dysmorphi$ OR dysmorphophobi$ OR imagine$ 
ugl$.mp; (c) a AND b.  
Study Selection 
The title and abstract of retrieved studies that contained search terms from both (a) and 
(b), that is (c), were screened by one author according to perceived relevance. The full-text 
articles of relevant studies were then reviewed by two authors and only included if they met the 
study inclusion and exclusion criteria. 
Data Item 
Data extracted from each study included the authors, publication date, population studied, 
location of study, number of participants (n), estimated prevalence and confidence interval in 
both sexes (both in total sample and in those diagnosed with BDD), mean age and range of 
participants (where available), method of screening, whether an interview was used to diagnose, 
and screening for any other disorders along with their prevalence (if available).  
Summary Measure 
The principal summary measures were the n, estimated prevalence, and confidence 
interval in the total and by sex.     
Synthesis of Results    
PREVALENCE OF BDD 7 
The prevalence of BDD in each sample was computed by dividing the number of 
diagnosed cases of BDD by the total number of participants/patients. To combine the prevalence 
estimates from the different settings we weighted the prevalence estimator by the sample size in 
each unit. To pool the prevalence data we used random effects logistic with exact binomial 
likelihood to model the within-study distribution. This analysis method was preferred to avoid 
bias due to many of the prevalence estimates being close to 0 (Hamza, van Houwelingen, & 
Stijnen, 2008). As the model is fit iteratively, explicit variance weightings for the studies are not 
available. A Z test assessed whether the proportion was different from 0, with τ2 testing between-
study variance of prevalence. Heterogeneity was assessed with a likelihood ratio test (χ2) 
comparing model fit for fixed and effects model and quantified, when possible, with I2 to 
determine the percentage of between-study variance which is due to heterogeneity rather than 
chance. Models were fit with the metaprop_one 1.2 (Nyaga, Arbyn, & Aerts, 2014) procedure in 
STATA 14.1 IC (Stata Corporation). As 95% confidence intervals based on the normal 
approximation are not accurate for prevalence estimates near the 0 or 1 boundary, we used 
the Agresti and Coull (1998) method to calculate confidence intervals using STATA (Stata 
Corporation). For the psychiatric inpatient setting, we removed the data on adolescents (n = 21) 
from the study by Grant, Kim, and Crow (2001) to enable the comparison with adult settings 
(Table 4). Data from studies in dermatology were separated into general dermatology settings, 
dermatology settings specializing in acne, and cosmetic dermatology settings (non-surgical 
procedures). When calculating overall weighted prevalence within each setting, we did not 
include studies that only included a single sex (i.e. female only studies). However these were 
included when weighted prevalence was calculated for each sex individually.   
    Results 
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Study Selection 
Figure 1 provides a flowchart of the systematic search, and the number of studies that 
were screened for eligibility and subsequently excluded or included in the final review. Four 
studies were excluded because they were not published in the English language; nine because 
they were comorbidity studies rather than studies of BDD prevalence; twelve because they did 
not provide a prevalence of BDD; five because they were literature or systematic reviews, or 
case studies; one because it specifically recruited patients with BDD only; two because they used 
data from a previous study; one because patients in its sample had real “defects”; three because 
no validated measure of BDD was used to diagnose the disorder; six because they were not 
investigating BDD (only body image, body dissatisfaction or “dysmorphic concern”); one as it 
was a conference abstract; one because it was a poster presentation, and one because it was an 
unpublished thesis study. 
Study Characteristics  
The characteristics of all studies extracted for inclusion are shown in Tables 2 to 13. The 
weighted prevalence for each sex and total for different settings is shown at the bottom of each 
table, along with measures of between-study heterogeneity. The locations of the studies were in 
Germany (5), France (1), USA (19), UK (4), Italy (5), Iran (4), Turkey (4), Sweden (1), Belgium 
(1), Chile (1), The Netherlands (2), Australia (2), Brazil (2), Pakistan (1), China (1), Taiwan (1), 
Japan (1), and Singapore (1). The prevalence and study characteristics of each of the settings will 
now be described.  
Methods of Screening  
A variety of tools was used to screen patients/participants for the presence of BDD. The 
BDDQ was the most commonly used, and has been validated against the SCID for use among 
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females in the community, with a sensitivity and specificity of 94% and 90% respectively 
(Brohede, Wingren, Wijma, & Wijma, 2013). It has also been validated against the SCID in a 
facial cosmetic surgery sample (Dey et al., 2015), with a sensitivity of 100%, specificity of 
90.7%. In addition, validation studies for the BDDQ have also been conducted in psychiatric 
outpatients with a sensitivity of 100% and specificity  of 89% (Phillips, Atala, & Pope, 1995), as 
well as a psychiatric inpatient sample (Grant et al., 2001): 100% sensitivity and 92.5% 
specificity. A modified version has been used in dermatology settings, the BDDQ-DV (Dufresne, 
Phillips, Vittorio, & Wilkel, 2001). This measure has been validated against the SCID for BDD 
and has 100% sensitivity and 92.3% specificity in a dermatology setting.  
The Cosmetic Procedure Scale (COPS) (Veale et al., 2012) has been validated in those 
seeking cosmetic surgery and has a sensitivity of 88.9% and specificity of 93.2%. It has been 
modified for identifying BDD in men preoccupied with penis size (COPS-P) (Veale, Miles, et 
al., 2015) and in women seeking labiaplasty (COPS-L) (Veale et al., 2013).   
The DCQ has also been validated in a dermatology outpatient setting, with a sensitivity 
of 72% specificity of 90.7% (Stangier, Janich, Adam-Schwebe, Berger, & Wolter, 2003), and a 
BDD outpatient setting: sensitivity 96.4% and specificity 90.6% (Mancuso, Knoesen, & Castle, 
2010).  
The BIDQ (Cash, Phillips, Santos, & Hrabosky, 2004) is modified from the BDDQ for 
more continuous scoring, but has not been validated against a SCID; therefore the sensitivity or 
specificity is not known and has not been adopted as a screening tool.   
A study of BDD in rhinoplasty surgery settings validated the BICI-SR (Persian version), 
and compared it to a “gold standard” psychiatric interview (Ghadakzadeh, Ghazipour, 
Khajeddin, Karimian, & Borhani, 2011). The original version of the BICI (Littleton, Axsom, & 
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Pury, 2005) displayed a low sensitivity (67%) and high specificity (96%) among a population of 
undergraduate students. Following on from this, the Persian version of this measure mentioned 
above was also found to have good sensitivity and specificity (93.5% and 80.8% respectively). 
Adults in the Community  
Seven (n = 13,773) studies were found on the prevalence of BDD in the community and 
the overall weighted prevalence was 1.9%. The characteristics and weighted prevalence of these 
studies are shown in Table 2. Prevalence ranged from 0.7% in the earliest study (Faravelli et al., 
1997), to 3.2% in the most recent study (Schieber, Kollei, de Zwaan, & Martin, 2015). In each of 
the studies that included both male and female subjects, prevalence of BDD was found to be 
higher among females (2.1%) than males (1.6%), which is a ratio of 1.27. Percentage of 
between-study heterogeneity in this setting, measured by I2, was substantial (55.0%). Three of 
the seven studies investigating BDD in the community also investigated prevalence of other 
disorders, with these studies reporting the prevalence of mood and anxiety disorders among their 
populations (see Table 2). 
Only two (Faravelli et al., 1997; Otto, Wilhelm, Cohen, & Harlow, 2001) of the seven 
studies used a clinical interview to diagnose BDD and neither of these used a defect severity 
scale. However, the interview selected for use varied, with Faravelli et al. (1997) choosing a 
“flow chart interview”, and Otto et al. (2001) choosing the Structured Clinical Interview (SCID) 
for DSM-IV (First, Spitzer, Gibbon, & Williams, 1995a). In addition, one study (Schieber et al., 
2015) used both the DSM-IV (American Psychiatric Association, 1994) and DSM5 (American 
Psychiatric Association, 2013) diagnostic criteria to diagnose BDD. This found that DSM5 
criteria reduced the prevalence slightly from 3.2 to 2.9%.  
Adolescents in the Community 
PREVALENCE OF BDD 11 
Only one study estimated the prevalence of BDD in adolescents in the community 
(Mayville, Katz, Gipson, & Cabral, 1999). 13 of 464 adolescents were found to meet DSM-IV 
diagnostic criteria for BDD (prevalence 2.2%; females (2.8%) and males (1.7%), which is a ratio 
of 1.64). Participants were screened with the Body Image Rating Scale (Mayville, Gipson, & 
Katz, 1998); however no structured clinical interview or defect severity scale was carried out to 
diagnose BDD. This may be particularly important in adolescents who are often self-conscious 
and worried about their appearance.  
Students 
Eight studies were found for the prevalence of BDD among University and College 
students (n = 3,516). The characteristics and weighted prevalence of these studies are shown in 
Table 3. Estimates ranged from 1.2% (Liao et al., 2010) to 5.8% (Taqui et al., 2008). The overall 
weighted prevalence across all studies was 3.3%, with a higher prevalence among females 
(3.6%) than males (2.2%), which gives a ratio of 1.64. The average age of students in these 
studies was 21.1 years old (SD 2.3). Percentage of between-study heterogeneity in this setting, 
measured by I2, was moderate (43.6%). None of the studies included, however, investigated 
prevalence of any other disorder within their population, and only one (Cansever, Uzun, 
Dönmez, & Özşahin, 2003) out of eight studies used a structured clinical interview to diagnose 
BDD and it did not use a defect severity scale. Five of the eight studies screened patients using 
the Body Dysmorphic Disorder Questionnaire (BDDQ) (Bartsch, 2007; Bohne, Keuthen, 
Wilhelm, Deckersbach, & Jenike, 2002; Bohne, Wilhelm, et al., 2002; Liao et al., 2010; Sarwer 
et al., 2005). Two of these studies also used the Dysmorphic Concern Questionnaire (DCQ) 
(Oosthuizen, Lambert, & Castle, 1998) in addition to the BDDQ (Bartsch, 2007; Liao et al., 
2010). One study stated that “some items” of the Body Dysmorphic Disorder Evaluation 
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(BDDE) were used to screen for BDD (Cansever et al., 2003), while another study used the self-
report version of the BDDE (BDDE-SR) (Boroughs, Krawczyk, & Thompson, 2010). Another 
study used the Body Image Disturbance Questionnaire (BIDQ) to screen students for BDD 
(Taqui et al., 2008).  
Family Doctor Surgeries 
We found only one study in a family doctor setting that examined the prevalence of 
somatoform disorders (that includes BDD in DSM-IV) (de Waal, Arnold, Eekhof, & Van 
Hemert, 2004). However, it did not use an adequate method of screening to detect BDD and did 
not find any cases. We describe this study as it highlights some of the problems that are likely to 
bias a study against finding cases of BDD. They screened 1046 consecutive patients aged 25–80 
years in a Dutch general practice with the SF-36 functional limitation questionnaire (Brazier et 
al., 1992), the Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983) and a 
physical symptom checklist. Of those defined as being at high risk, 80% received a standardised 
diagnostic interview (Schedule for Clinical Assessment in Neuropsychiatry (Wing et al., 1990). 
The prevalence of DSM-IV anxiety disorders was 5.5%, depressive disorder: 5.5%, somatoform 
disorders: 16.1%, and undifferentiated somatoform disorder: 13.1%. The latter includes one or 
more unexplained physical symptoms (e.g. fatigue, headache) that cause clinically significant 
distress or impairment. They found no cases of BDD.  However, the study excluded anyone 
under the age of 25, which is where we would expect many of the BDD cases to occur (Phillips, 
1991). In addition, none of the screening tools used for depression or anxiety enquired about 
symptoms of BDD, and the Schedule for Clinical Assessment in Neuropsychiatry (SCAN) that 
was used is inadequate for detecting BDD, as there is only one question that asks whether 
subjects’ appearance may have changed recently. 
PREVALENCE OF BDD 13 
Adult Psychiatric Inpatients 
Four studies (n = 788) were found on the prevalence of BDD in adult inpatient 
psychiatric wards. The characteristics and weighted prevalence are shown in Table 4. The overall 
weighted prevalence across all studies was 7.4%, with a higher prevalence among females 
(9.6%) than males (5.6%), giving a ratio of 1.71. The prevalence for BDD varied widely between 
studies from 1.9 – 16.0%. This may be related to the relatively small sample size and wide 
confidence interval in three of the four studies (n = 100-155). The prevalence rate in an inpatient 
setting is also likely to vary depending on the diagnostic intake. Thus, two of the inpatient 
settings in the USA had a high prevalence of mood disorder: 55.0% in Conroy et al. (2008) and 
75.0% in Grant et al. (2001). We also might expect a higher rate of BDD in those identified with 
substance misuse, which was diagnosed in 50.8% of the sample in Grant et al. (2001) but in only 
2.0% of Conroy et al. (2008). A key finding in all these studies was that BDD was poorly 
identified as none of the patients revealed their symptoms of BDD during a routine history. This 
was mainly reported to be because of shame or lack of knowledge about BDD or its treatment, or 
a desire to avoid the problem. Percentage of between-study heterogeneity in this setting, 
measured by I2, was substantial (72.6%). 
Adolescent Psychiatric Inpatients 
Two studies (n = 229) were found on the prevalence of BDD in adolescent inpatient 
psychiatric wards. The characteristics and weighted prevalence are shown in Table 5. The overall 
weighted prevalence was the same for adolescents as for the adult inpatients (7.4%), again with a 
higher prevalence among females (6.9%) than males (3.5%) with the ratio being 1.97. However, 
one of the two studies was much larger, contributing to 90.8% of the weighting (Dyl, Kittler, 
Phillips, & Hunt, 2006). This screened adolescents using the BDDQ (Phillips, 1996), but did not 
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use a SCID. The findings may therefore be biased. In this study, similar to the adult settings, 
bipolar disorder (40.4%) and major depressive disorder (MDD) (39.4%) were the most common 
diagnoses in the adolescent inpatients.  
Adult Psychiatric Outpatients 
Three studies (n = 765) were found for the prevalence of BDD in mainly specialist 
outpatient settings. The characteristics and weighted prevalence of these studies are shown in 
Table 6. The overall weighted prevalence across all studies was 5.8%, with a higher prevalence 
among females (6.5%) than males (4.6%), with the ratio being 1.41. Percentage of between-study 
heterogeneity in this setting, measured by I2, was moderate (47.7%). All studies used a clinician-
administered SCID to diagnose BDD. The prevalence ranged from 3.2% (Zimmerman & Mattia, 
1998) to 11.0% (Kelly, Zhang, & Phillips, 2015). Major depressive disorder was the most 
common primary diagnosis in two of the three outpatient studies: 54.8% (Zimmerman & Mattia, 
1998); 46% (Kelly et al., 2015), while social phobia was also found to be relatively common in 
two studies: 15.2% (Wilhelm, Otto, Zucker, & Pollack, 1997); 29% (Zimmerman & Mattia, 
1998).  
General Cosmetic Surgery 
Eleven studies (n = 2,291) were found for the prevalence of BDD in cosmetic settings. 
The characteristics of the studies are shown in Table 7. Prevalence ranged very widely from 
6.3% (Altamura, Paluello, Mundo, Medda, & Mannu, 2001) to 53.0% (Vindigni et al., 2002), 
and the overall weighted prevalence for BDD in this setting was 13.2%.  
In direct contrast to the majority of other settings, the prevalence of BDD in this setting 
was higher among males (15.3%) than females (10.9%) with the ratio being 0.71. The percentage 
of between-study heterogeneity in this setting, measured by I2, was considerably higher (90.0%).  
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There were no patterns in the use of a screening tool, with two studies using the Yale-
Brown Obsessive Compulsive Disorder scale, modified for BDD (BDD-YBOCS) (Altamura et 
al., 2001; Bellino et al., 2006). Strictly speaking, this is used to measure the severity of BDD 
symptoms and is not a diagnostic tool. One study used the BDDQ (Dey et al., 2015), two studies  
the Multidimensional Body-Self Relations Questionnaire (MBSRQ) (Sarwer, Wadden, 
Pertschuk, & Whitaker, 1998; Vargel & Uluşahin, 2001), and two studies the BDDE and BDDE-
SR respectively (Sarwer, Wadden, et al., 1998; Vindigni et al., 2002).  
There was no consistency in the interview conducted, with two studies merely stating that 
“an interview” was used to diagnose BDD (Ishigooka et al., 1998; Vargel & Uluşahin, 2001), 
three studies stating the use of the BDD-SCID-I (Altamura et al., 2001; Bellino et al., 2006; Dey 
et al., 2015), two studies citing the BDD-SCID-II (Aouizerate et al., 2003; Vindigni et al., 2002), 
one study using the MINI-International Neuropsychiatric Interview (MINI) (Pavan et al., 2006), 
and three studies failing to use a clinical interview at all. Only three of these studies utilised a 
defect severity scale to rate the perceived defects in their participants.  
Sensitivity analysis conducted on data in this setting revealed that when potential outliers 
were removed (Pavan et al., 2006; Vindigni et al., 2002), as both reported BDD prevalence 
figures were considerably higher than they were in other studies in this setting, between-subject 
heterogeneity was no longer significant, and I2 was reduced to 0.0, suggesting that these two 
studies may have had an effect on the weighted prevalence figure in cosmetic surgery clinics. It 
is not known why these studies found a prevalence of BDD so much higher than elsewhere, as 
both used some form of structured clinical interview. However, it is clear that in this setting there 
is inconsistency in the screening and testing for BDD, which may lead to overestimation. 
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Excluding Vindigni et al (2002) and Pavan et al (2006) reduces the prevalence estimate from 
13.2% to 7.6% (CI 5.6-10.3%).  
Rhinoplasty Surgery 
Seven studies (n = 1,001) were found for the prevalence of BDD in rhinoplasty surgery 
candidates. The characteristics and weighted prevalence of these studies are shown in Table 8. 
Prevalence figures in this setting range from 1.8% (Picavet et al., 2012) to 31.5% (Fathololoomi, 
Goljanian, Fattahi, Noohi, & Makhdoom, 2013). This category therefore seems to represent the 
greatest degree of uncertainty in the diagnosis of BDD. We calculated a weighted prevalence of 
20.1%. There was a slightly higher prevalence among males (18.4%) than females (16.7%), with 
the ratio being 0.91. Percentage of between-study heterogeneity in this setting, measured by I2, 
was considerable (90.5%). One study investigated the prevalence of BDD only among secondary 
rhinoplasty candidates (Constantian, 2012). Four of seven studies stated the use of a structured 
diagnostic interview, with one citing a DSM-IV semi-structured interview (Ghadakzadeh et al., 
2011), two stating the use of the BDD-YBOCS (Picavet et al., 2012; Veale, De Haro, & 
Lambrou, 2003), and one just stating “a clinical interview” was used to diagnose BDD (Felix et 
al., 2014). There was also no consistency in the way that BDD was screened for, with one study 
stating that the DSM-IV (American Psychiatric Association, 1994) was used to screen 
participants while another stated that the DSM-IV-TR (American Psychiatric Association, 2000) 
was used to screen for BDD (Alavi, Kalafi, Dehbozorgi, & Javadpour, 2011). One study opted to 
use the BDDQ to screen for BDD (Veale, De Haro, et al., 2003), while another used a Brazilian 
version of the BDDE (Felix et al., 2014). A further study actually validated a Persian, self-report 
version, the Body Image Concern Inventory (BICI-SR) (Ghadakzadeh et al., 2011), while 
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another merely stated that a “4-item BDD questionnaire” was used to screen for BDD 
(Fathololoomi et al., 2013).  
Five of the seven used a defect severity scale (Constantian, 2012; Felix et al., 2014; 
Ghadakzadeh et al., 2011; Picavet et al., 2012; Veale, De Haro, et al., 2003), therefore suggesting 
that two did not assess the presence of a perceived defect at all. However, the type of scale used 
again varied from study to study. Two studies used a clinician-rated 2-point scale, with “1” 
representing no defect/slight defect and “2” representing a clear defect (Felix et al., 2014; 
Ghadakzadeh et al., 2011). One study used a clinician-rated 1- to 5-point scale, with “1” 
representing no deformity, and “5” representing the worst deformity (Constantian, 2012), while 
another used a clinician-rated 25-point nasal deformity scale, with “25” representing a perfect 
nasal tip (Picavet et al., 2012).  
Orthognathic Surgery 
Only two studies (n = 259) were found for the prevalence of BDD in orthognathic 
surgery settings. The characteristics and weighted prevalence of these studies are shown in Table 
9. In this setting, the prevalence of BDD across the two included studies ranged from 10% to 
13.1%. Our estimated weighted prevalence was 11.2% (13.2% in women and 8.0% among men, 
giving a ratio of 1.65).  
Only one study investigated the presence of other axis I disorders, concluding a 
prevalence of obsessive compulsive disorder (OCD) in 29.3%, MDD in 16.2%, and anxiety 
disorders in 23.2% (Collins, Gonzalez, Gaudilliere, Shrestha, & Girod, 2014). Only one study 
(Vulink et al., 2008) implemented a clinician-rated defect severity scale (1-4; 1 = no defect, 4 = 
severe defect). Vulink et al. (2008) used questions from the BIDQ and BDDE to screen 
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participants, and followed the DSM-IV criteria for BDD, while Collins et al. (2014) screened 
patients with the BIDQ but did not use a clinical interview.  
Orthodontics/Cosmetic Dentistry 
Three studies (n = 480) were found for the prevalence of BDD in those having 
orthodontic treatment or cosmetic dental surgery (Table 10). In these studies, prevalence ranged 
from 4.2% to 7.5%. The estimated weighted prevalence of BDD (5.2%), showed a higher 
prevalence among females (7.9%) than males (2.5%), giving a ratio of 3.16. Only one study used 
a semi-structured interview to diagnose BDD (Hepburn & Cunningham, 2006); however, de 
Jongh, Aartman, Parvaneh, and Ilik (2009) used no screening tool or clinical interview, but 
followed the DSM-IV criteria for BDD.  
Vulvo-Vaginal Surgery  
One study (Veale, Eshkevari, et al., 2014) was found for the prevalence of BDD in 
women seeking labiaplasty (n = 49). In this study, prevalence was 18.4%. They used a validated 
screening questionnaire for this population (Veale et al., 2013) and the BDD-SCID for DSM-IV 
(Phillips et al., 1995) to diagnose patients with BDD pre and also post-operatively (Veale, 
Naismith, et al., 2014). 
General Dermatology Outpatients 
Five studies (n = 914) were found for the prevalence of BDD in general dermatology 
settings, while two of these studies also investigated prevalence of BDD in cosmetic 
dermatology settings (n = 301) (Table 11). The range for the prevalence was from 4.2% 
(Dogruk-Kacar et al., 2014) to 29.4% (Hsu, Ali Juma, & Goh, 2009). The percentage of 
between-study heterogeneity in this setting, measured by I2, was considerably higher (87.8%). As 
this measure of heterogeneity was so high, sensitivity analysis was carried out, and after 
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excluding the one study (Hsu et al., 2009) that seemed to be a clear outlier, with a prevalence of 
29.3% compared to all other studies who reported prevalence < 15%, heterogeneity was reduced, 
along with I2  (27.0%). This suggests that this heterogeneity was partly due to outliers.   
All five studies used the BDDQ, with four of those five (Calderon et al., 2009; Conrado 
et al., 2010; Dogruk-Kacar et al., 2014; Hsu et al., 2009) using the version modified for use in 
dermatology settings (Dufresne et al., 2001). However, only two of the five studies then went on 
to use the clinician-administered BDD-SCID to diagnose BDD (Conrado et al., 2010; Phillips et 
al., 2000). Our results suggest a weighted prevalence of BDD in general dermatology outpatient 
settings of 11.3% (13.4% in females and 14.0% in males, with a ratio of 0.96).  
In addition, three of the five included studies also investigated defect severity, using a 5-
point scale in which “1” represented no defect/flaw, while “5” represented a severe defect/flaw. 
Two of these were dermatologist-rated, while one was psychiatrist-rated.  
Cosmetic Dermatology Outpatients 
Two original studies and three of the studies investigating prevalence of BDD in 
dermatology settings also reported figures in a cosmetic dermatology clinic (see Table 12). 
Prevalence of BDD in cosmetic dermatology clinics ranged from 2.9% to 15.2%, with one study 
(Conrado et al., 2010) stating a much higher prevalence of BDD among women (14.7%) than 
men (7.1%). Percentage of between-study heterogeneity in this setting, measured by I2, was non-
existent (0.0%). For the five studies investigating prevalence of BDD in cosmetic dermatology 
clinics, the weighted prevalence was calculated to be 9.2%. As only one study specified numbers 
of males and females within the sample, the weighted prevalence for each sex could not be 
calculated.    
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Three studies used the BDDQ modified for dermatology (BDDQ-DV) (Dufresne et al., 
2001) to screen patients for possible BDD, one used the regular BDDQ, and one used the DCQ. 
Four of the five studies (Castle, Molton, Hoffman, Preston, & Phillips, 2004; Conrado et al., 
2010; Dufresne et al., 2001; Phillips et al., 2000) used a SCID to diagnose patients with BDD 
following this screening process. All five studies also implemented a defect severity scale in 
order to rule out the presence of those with actual defects in their appearance. In these studies, if 
patients received a defect severity score of 0-2 (little to no defect) they were classified as being 
eligible for a BDD diagnosis.  
All Cosmetic Surgery and Cosmetic Dermatology Settings  
 The estimated prevalence for all 23 cosmetic surgery settings was 12.2% (CI 8.4- 17.4). 
Given the wider range of cosmetic surgery settings a high heterogeneity is expected (I2 = 91.1%).  
Acne Clinics 
Two studies were separated from the general dermatology setting as they investigated the 
prevalence of BDD among those with acne vulgaris (see Table 13). The weighted prevalence of 
BDD was estimated to be 11.1%.  
 Both studies implemented a defect severity scale, which were specific skin lesion-related 
rating scales: the Cook scale (Cook, Centner, & Michaels, 1979), and the Allen & Smith scale 
(Allen & Smith, 1982), both of which were rated on a 9-point scale (0 = mild skin 
problems/almost clear skin; 8 = severe skin problems/skin nearly full of lesions). One study 
screened patients using the BDDQ-DV but did not use a SCID (Bowe, Leyden, Crerand, Sarwer, 
& Margolis, 2007), while the other did not use a screening questionnaire but did use a SCID 
(Uzun et al., 2003). A weighted prevalence of 11.1% was calculated for BDD in acne clinics. A 
PREVALENCE OF BDD 21 
weighted prevalence for males and females could not be calculated as only one study provided 
details on gender. 
Female Ballet Dancers and Male Weight Lifters  
One study investigated the prevalence of BDD among female ballet dancers (n = 19) 
(Nascimento, Luna, & Fontenelle, 2012), and one study among male weight lifters (n = 648) 
(Nieuwoudt, Zhou, Coutts, & Booker, 2015). As these were the only studies of this kind, 
weighted prevalence could not be calculated. Prevalence figures for these two populations were 
similar: 10.5% (CI: 1.7 - 32.6) of female ballet dancers, and 10.6% (CI: 8.5 - 13.3) of male 
weight lifters. Nascimento et al. (2012) used the somatoform SCID and MINI to diagnose 
dancers with BDD, while Nieuwoudt et al. (2015) used only the BDDQ to screen for BDD. 
Neither study used a defect severity scale. Prevalence for eating disorders was 33.8% among 
male weight lifters while prevalence of panic disorder, generalised anxiety disorder and 
dysthymic disorder was 10.5% for all.  
 
     Discussion 
This is the first systematic review on the prevalence of BDD in various settings. We 
found BDD to have an estimated weighted prevalence of 1.9% of adults in the community and 
3.3% in student populations. The prevalence rate rises to 7.4% in psychiatric inpatients and 5.8% 
in outpatients, where it was under-identified. The prevalence is highest in dermatological settings 
(11.3%), general cosmetic surgery (13.2%) and rhinoplasty settings (20%). Between-study 
heterogeneity was highest among cosmetic surgery settings, suggesting that this data is less 
reliable.  
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To put the estimates in context, the prevalence of BDD in the community is higher than 
other body image disorders such as anorexia nervosa or bulimia nervosa (average prevalence of 
0.3% and 1% respectively (Hoek, 2006). However, the diagnosis of Other Specified Feeding and 
Eating Disorders (OSFED), formerly Eating Disorders Not Otherwise Specified (EDNOS) in 
DSM-IV, tends to be higher than BDD (2.4%) (Solmi, Hotopf, Hatch, Treasure, & Micali, 2015). 
BDD is however more common than schizophrenia (0.5%) (Saha, Chant, Welham, & McGrath, 
2005) but less common than a major depressive episode (prevalence of 6% based on 25 studies 
and 106,628 participants) (Cuijpers & Smit, 2002). Our estimated prevalence of BDD may be 
biased upwards as only some of the studies used a diagnostic interview to exclude body 
dissatisfaction or had an effective method for excluding participants with a noticeable defect.   
Whatever the true prevalence, BDD appears common in the community but only a small 
proportion seeks evidence-based treatment. For future research, it would be of interest to know 
what proportion of those identified in the community have a significant interference in their life, 
the number who would identify themselves as having BDD, the proportion who have sought help 
from a mental health professional, a dermatologist, or cosmetic practitioner and the obstacles to 
seeking help.  
Sex Ratio 
There was a sex ratio of 1.27 for women to men in the community. In students, there was 
a ratio of 1.64 for women to men.A greater preponderance of women may reflect the less severe 
end of the spectrum compared to a specialist psychiatric service, where there tends to be equal 
sex ratio (Phillips et al., 2006). Of note is that the sex ratio was reversed in general cosmetic 
surgery settings with the ratio being 0.71 and in rhinoplasty settings the ratio being 0.91. This 
partly reflects the population having rhinoplasty which is the most common cosmetic procedure 
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in men in the USA (American Society of Plastic Surgeons, 2014) and where the ratio between 
women and men is 0.44.  
This is in stark contrast to the female to male ratio of 11.5 in those having cosmetic 
surgery in the USA (American Society of Plastic Surgeons, 2014). This suggests that meeting 
criteria for BDD is notably higher among male compared to female cosmetic surgery-seekers. 
Information on sex ratio was missing from the majority of studies in cosmetic dermatology 
settings. The context is that in the US, Botox injections are the most common minimally invasive 
cosmetic dermatological procedure, in which 6.2 million women had Botox in 2014 compared to 
just 411,000 men (American Society of Plastic Surgeons, 2014). Again we may expect a reversal 
of the sex ratio in BDD in cosmetic dermatology similar to cosmetic surgery settings. Further 
research is also required on gender in general dermatology settings.  
Culture 
All the community studies were carried out in either Europe or the USA Thus nothing is 
known about the prevalence of BDD in under-developed countries and in cultures where 
cosmetic procedures are popular (for example in Brazil) or in fundamentalist societies where 
modesty in one’s dress is emphasised. Studies in rhinoplasty settings found the highest 
prevalence figures in studies in Iran and Brazil. However, this data needs to be contextualised in 
terms of the high popularity of rhinoplasty in these cultures.  
Previous research in body dissatisfaction has found differences between countries of low 
and high socio-economic status (van den Berg, Mond, Eisenberg, Ackard, & Neumark-Sztainer, 
2010), and between rural and urban settings (Swami, Kumaraswami, & Furnham, 2011). Swami 
et al. (2011) concluded body dissatisfaction was highest in America, and suggested that 
differences may be due to aspects of their environment, for example media exposure. Therefore, 
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studies in this review may not be representative of the prevalence of BDD in a non-American or 
Western culture.   
Age 
The estimate in adolescents (2.2%) has a wide confidence interval as there was only one 
study and 464 participants. One might expect a higher rate of BDD in young people, when self-
consciousness about one’s body is highest. However the presentation of BDD in adolescent 
psychiatric services is less than in adult services (Phillips et al., 2006). Further large prevalence 
studies are required in schools and colleges with a diagnostic interview to ensure it is possible to 
differentiate those with body dissatisfaction and body image problems best explained by 
disordered eating. The estimation of the weighted prevalence of BDD among students of 3.3% is 
higher than in the community, as might be expected, as students are predominantly young adults 
who are at greater risk of developing BDD.  
 None of the studies in students  used a structured diagnostic interview, raising the 
possibility of bias. In addition, these studies did not generally screen for other psychiatric 
disorders and it is therefore difficult to put the prevalence in context. Further research should aim 
to investigate the prevalence of BDD through the use of structured clinical interviews after 
screening, and to understand the proportion of young people whose symptoms of BDD are 
interfering with their studies or causing them to drop out of their studies, and to assess whether 
student welfare counsellors are adequately trained to identify BDD and advise on treatment.  
Psychiatric settings 
The weighted prevalence of BDD in adult and adolescent inpatient settings was 7.4%. 
However the numbers within each study are small (and therefore there is a wider confidence 
interval than say studies in the community) but they did all have a structured diagnostic 
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interview. The majority of patients identified in these inpatient settings had a comorbid diagnosis 
either of depression, substance misuse or an anxiety disorder, any of which is likely to increase 
the overall prevalence of BDD. These particular studies do not reflect the prevalence of BDD in 
many state institutions where there is a much higher prevalence of psychosis. In addition, these 
studies only reflect the presence of BDD in western hospitals (as all studies were either taken 
from the USA or Europe). However, there is one consistent finding across the four studies: that 
clinicians poorly identified BDD. None of the patients revealed their symptoms of BDD during a 
routine history. This was mainly because of shame or lack of knowledge about BDD or its 
treatment or a desire to avoid the problem (Veale, Akyüz, et al., 2015). However, further 
research needs to examine why professionals do not conduct a systematic diagnostic interview:  
too often it seems that they limit their assessment to the patient’s history, a mental state 
examination and a risk assessment, or they do not use a diagnostic screening questionnaire. 
Screening for BDD should at least be targeted at those who present with a diagnosis of 
depression, substance misuse, obsessive-compulsive disorder, or an anxiety disorder. Relatively 
little investment in training would be required to ensure patients are offered appropriate 
treatment in both psychiatric in-patients and community settings. One might expect a higher 
prevalence in adolescent psychiatric settings when there is higher sensitivity about body image 
and in a western culture where body dissatisfaction is rife. Further research is required in this 
area and to further understand the reluctance of professionals to screen for BDD in these settings.  
The studies conducted in outpatient settings may not be typical of outpatients as two of 
the three studies were conducted among more specialised populations, in veterans and in an 
anxiety disorders clinic. The prevalence in psychiatric outpatient or community settings will 
largely depend on the nature of the population. Like the inpatient settings, it is important to target 
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the screening for BDD where there is a high proportion of mood, anxiety, obsessive compulsive 
or eating disorders.  
Cosmetic Settings   
The prevalence of BDD was highest in cosmetic settings especially rhinoplasty clinics, 
with prevalence figures varying dramatically. However these settings represent the poorest 
quality studies with the highest heterogeneity. A defect severity scale was often not used and 
some studies may therefore be over-diagnosing BDD if there are “noticeable” defects. Equally 
some patients may not disclose exactly how they feel as they may fear being turned down for 
surgery. The prevalence may vary widely depending on gender; whether a structured diagnostic 
interview was used; and nature of the procedures (for example type change procedures like 
rhinoplasty versus restorative procedures, for example rhytidectomy). The implications of a 
relatively high prevalence rate are not fully understood are as there are very few studies that 
follow up after surgery those patients diagnosed with BDD. If the prevalence rate is as high as 
13.1% then the most important research is to determine the rate of dissatisfaction and prevalence 
of BDD after surgery in those diagnosed prospectively. One very small prospective study of 
patients diagnosed before surgery (Tignol, Biraben-Gotzamanis, Martin-Guehl, Grabot, & 
Aouizerate, 2007) found that many patients were satisfied with the results but that their 
symptoms of BDD remained after surgery. Future research may be better targeted at identifying 
BDD in specific procedures, which may be more risky in say rhinoplasty compared to 
mammoplasty augmentation or reduction. Whether one can then engage individuals with BDD 
from a cosmetic setting in an evidence-based treatment is also unknown, as all previous studies 
have recruited subjects who are seeking help at a specialist psychiatric setting.  
Only one study was found within a vulvo-vaginal setting; therefore a weighted 
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prevalence figure was not calculated. The prevalence from this study was 18.4%; however, the 
confidence interval was very wide as the sample size was small. The motivation for labiaplasty 
may be functional (e.g. discomfort), appearance/cosmetic, or sexual dysfunction (Goodman et 
al., 2010; Veale, Eshkevari, et al., 2014) but the outcome for those with BDD was good (Veale, 
Naismith, et al., 2014). Further research is required to determine the prevalence of BDD in this 
setting and its relevance to outcome in the long term.  
Importantly there are no large prospective studies in cosmetic surgery settings to 
determine the degree of risk for outcome in terms of satisfaction or whether the diagnosis of 
BDD persists especially in those with a single concern and at the milder end of the spectrum. 
While structured interviews and defect evaluations were often conducted, there was no 
consistency in the method that this followed. Problems may arise in the inter-rater agreement of 
defining a perceived “defect”. This raises questions about the diagnosis of BDD in all cosmetic 
settings. For example it may be more helpful to have a standardised assessment of the nose for 
rhinoplasty (Ifeach, Magarey, & Saleh, 2014) and to evaluate the degree of discrepancy, for 
example self- compared to clinical-rating, of the perceived defect (Stangier, Hungerbühler, 
Meyer, & Wolter, 2000) or between self and ideal ratings (Veale, Kinderman, Riley, & Lambrou, 
2003) or between self- and  a clinical-rating of outcome post-surgery to determine if these or the 
functional impairment of BDD are better predictors of dissatisfaction and persistence of 
symptoms of BDD.  Clinical ratings of a perceived defect should have a high degree of inter-
rater reliability and external validity.  
Dentistry 
Cosmetic dental clinics found the prevalence of BDD was 5.2%. This is lower than the 
prevalence in orthognathic surgery settings (11.2%), which seems counterintuitive as cosmetic 
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dentistry is usually optional and involves procedures designed to improve the appearance of 
teeth, e.g. veneers, whereas orthognathic surgery involves more invasive procedures which one 
would associate rather with a physical defect that warrants correction. There is a lack of 
prevalence studies examining the prevalence of BDD in adolescents undergoing orthodontic 
work and of outcome in those diagnosed with BDD.      
Dermatology  
A weighted prevalence of 11.3% in dermatology outpatient clinics was found However, 
again there was a wide confidence interval (6.0 - 20.2), and heterogeneity was shown to be 
strongly affected by an outlier study. This may reflect the nature of the setting (e.g. state vs. 
private), which differ in the types of referrals. There was somewhat more consistency in this 
setting, with all studies using the BDDQ to screen for BDD (some using the original form and 
some using the version adapted for dermatology settings). In addition, there was a mix of studies 
using a structured clinical interview or some form of defect severity scale. Research is required 
on the implications of the diagnosis for outcome in dermatological treatment.  
Threshold for Diagnosis 
For all the settings above, there may be a concern about the threshold for a diagnosis of 
BDD and whether body dissatisfaction is being drawn into a clinical domain. This is a similar 
concern to other psychiatric disorders, for example the medicalization of normal sadness by 
turning grief and other life stresses into a major depressive episode (Dowrick & Frances, 2013) 
or marked shyness into social anxiety disorder (Scott, 2006; Wakefield, Horwitz, & Schmitz, 
2005).  
Although the boundaries between BDD and “body dissatisfaction” or a noticeable bodily 
defect(s) can be made reliable by a structured interview and defect severity scales by more than 
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one interviewer, it does not make a diagnosis more valid. However, there are also concerns about 
where to draw the line for the prevalence of body dissatisfaction using the Multidimensional 
Body-Self Relations Questionnaire (MBSRQ: Cash (2000)). Various studies estimate body 
dissatisfaction to be between 13.4% - 31.8% among women and 9.0% - 28.4% among men 
depending on the criterion used (Fallon, Harris, & Johnson, 2014) or 34% in men and 38% in 
women  (Cash & Henry, 1995) and 43% in men and 56% in women (Garner, 1997).   
Limitations  
A weighted prevalence provides greater weighting to studies with larger numbers and 
does not take into account the quality of the study. Due to the high heterogeneity especially 
within cosmetic settings, therefore, there are limitations with regard to the calculation of the 
weighted prevalence and setting of the boundary for BDD. The heterogeneity may be due to the 
method of screening or diagnosis or the location of each study. Better research is required to 
ensure a diagnosis is made with a structured diagnostic interview with inter-rater reliability and 
agreed instruments for a “defect” especially in cosmetic settings.  
Conclusions 
We noted in the introduction that large catchment area surveys of psychiatric 
epidemiology have generally ignored screening for BDD. However, our review has found that 
the surveys of BDD have sometimes ignored screening for other psychiatric morbidity. This 
sometimes makes it difficult to put the estimated prevalence in context. It is to be hoped that this 
will change in future as BDD is now more recognized and is an integral part of the obsessive 
compulsive and related disorders section of DSM5 (American Psychiatric Association, 2013) and 
ICD-11 (Veale & Matsunaga, 2014).  
Our conclusion is that BDD remains a hidden but common disorder with many people not 
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seeking help or seeking help inappropriately. The design of many of the studies could be 
improved upon, especially in cosmetic settings. Further research is required on increasing 
awareness of BDD and its identification in settings where there is a high risk of BDD.   
Health professionals are often not confident enough to diagnose and treat BDD. Due 
mainly to shame, it is under-reported and then under-diagnosed. A patient must pass several 
obstacles in the successful diagnosis and treatment of their BDD. There is still a low level of 
awareness and understanding about BDD amongst the public and health professionals. As a 
result, detection rates are low. The second obstacle is that when people with BDD do seek help 
they are more likely to present in a dermatological, cosmetic or orthognathic setting than a 
psychiatric one. Here the prevalence ranged from 9.2 to 20.1%. When someone with BDD 
obtains obtain help from a mental health professional, they may be too ashamed to reveal their 
main symptoms and present with symptoms of depression, social phobia, or obsessive-
compulsive disorder (for which there is frequent comorbidity). In these settings, the prevalence 
rose to 7.4%. When sufferers are finally diagnosed with BDD, 10-15 years after the onset 
(Phillips, Menard, Fay, & Weisberg, 2005; Veale, Boocock, et al., 1996), they may then be 
treated inappropriately with counselling or antipsychotic drugs.    
Whilst awareness of the condition in the general public may improve over time, it is still 
a major obstacle for an individual with BDD to reveal their symptoms even when it is their 
biggest problem. Thus, in psychiatric settings it is the responsibility of the mental health 
professional to screen for BDD just as they ask about alcohol or plans for suicide – issues which 
patients may not volunteer in their history. Further research needs to understand why 
professionals do not conduct a broader diagnostic interview especially when there is a 
presentation of depression, substance misuse or social anxiety – too often an assessment is 
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limited to a patient’s history, mental state examination and risk assessment. Patients may 
continue to be treated inappropriately if screening is not done for BDD and no attempt is made to 
engage a patient in CBT which is specific to BDD (Veale, Anson, et al., 2014; Veale, Gournay, 
et al., 1996; Wilhelm et al., 2014) or offer a SSRI in the maximum tolerated dose (Phillips, 
Albertini, & Rasmussen, 2002). 
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Figure 1.  
Search strategy employed using Embase, Ovid Medline, and PsychInfo databases 
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Table 1.  
Search conducted using Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and 
Ovid MEDLINE(R): 1946 to Present, Embase: 1974 to 2015 July 06, and PsycINFO: 1806 to 
June Week 5 2015. Authors searched through articles that contained search terms from both 
stage 1 and 2, i.e. 1,672 articles.  
 
 
Stage Search terms Result 
1 
epidemiology  
OR  
epidemiologic studies  
OR incidence  
OR prevalence  
OR occur*  
OR frequenc*  
OR proportion*  
OR rate*  
OR number*  
OR percent* 
15249547 
2 
body dysmorphic disorder.sh.  
OR body dysmorphi$  
OR dysmorphophobi$  
OR imagine$ ugl$ 
4718 
3 1 AND 2 1672 
4 Duplicates removed 622 
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Table 2. Prevalence of BDD in adults in the community 
Reference 
Location 
(Recruitment 
period) 
BDD 
screening 
tool 
Interview 
Age  
mean (SD) 
range 
Participants n (%) with BDD [CI (95%)] Other disorders 
Total Male Female Total Male Female 
 
Faravelli et al. 
(1997) 
 
Italy 
(April - Sept. 
1990) 
 
None 
 
“Flow chart 
interview 
following the 
DSM-III 
decision tree” 
 
- 
 
673 
 
304 
 
369 
 
5  
(0.7%) 
[0.3, 1.8] 
 
0  
(0.0%) 
[0.0, 1.5] 
 
 
5  
(1.4%) 
[0.5, 3.2] 
 
Mood dis: 84(12.2%)  
BPA dis: 1  
Dysthymia: 46(6.8%) 
Cyclothymia: 9(1.3%) 
MDD: 28(4.2%) 
Panic with ag: 
3(0.4%) 
Panic without ag:18 
(2.7%) 
Agoraphobia without 
panic: 1 
Simple phobia: 2 
(0.3%) 
 GAD: 3 (0.4%). 
Otto et al. 
(2001) 
 
USA 
(point 
prevalence- 
no year 
given) 
 
None SCID-P for 
DSM-IV 
36-44 -  
 
 
0 976  
female 
only  
 
- 
 
 
- 8  
(0.8%) 
[0.4, 1.6] 
Anxiety dis: 
211(21.6%) 
MDD: 318(32.6%). 
Rief, 
Buhlmann, 
Wilhelm, 
Borkenhagen, 
and Brahler 
(2006) 
Germany 
(Sept. - Oct. 
2004) 
 
  
Two surveys 
assessing 
DSM-IV-
TR criteria 
for BDD  
No interview 47.6  
(18.0) 
14-99 
2552 906 1346 43  
(1.7%) 
[1.3, 2.3] 
17  
(1.9%) 
[1.2, 3.0] 
26  
(1.9%) 
[1.3, 2.8] 
-  
PREVALENCE OF BDD 55 
Koran, 
Abujaoude, 
Large, and 
Serpe (2008) 
 
 
USA 
(Spring - 
Summer 
2004) 
 Some 
questions 
from BDDQ 
 
No interview - 2048 739 1309 49  
(2.4%) 
[1.8, 3.2] 
16  
(2.2%) 
[1.3, 3.5] 
33 
(2.5%) 
[1.8, 3.5] 
- 
Buhlmann et 
al. (2010) 
Germany 
(May - June 
2007) 
Two surveys 
assessing 
DSM-IV-
TR criteria 
for BDD  
 
 
No interview 46.9  
(18.4) 
14-93 
 
2510 1215 1295 45  
(1.8%) 
[1.3, 2.4] 
17  
(1.4%) 
[0.9, 2.3] 
28  
(2.2%) 
[1.2, 2.8] 
- 
Brohede, 
Wingren, 
Wijma, and 
Wijma (2015) 
 
 
Sweden 
(Oct. - Nov. 
2009) 
BDDQ 
(Swedish v.) 
No interview 18-60 - 
 
0 2885 
female 
only 
- - 61  
(2.1%) 
[1.7, 2.7] 
Depression: 287 
(9.9%) 
Anxiety: 927 (32.1%) 
Schieber et al. 
(2015) 
Germany 
(May - June 
2011) 
DCQ 
(DCQ score 
>9 = 
dysmorphic 
concerns) 
 
Patient listed 
and rated 
their own 
flaws 
DSM-IV 
diagnostic 
criteria 
 
DSM-5 
diagnostic 
criteria 
45.3  
(13.0) 
18-65 
2129 976 1153 DSM-IV:  
68 (3.2%) 
[2.5, 4.0] 
 
DSM-5:  
62 (2.9%) 
[2.3, 3.7] 
 
17 (1.7%) 
[1.1, 2.8] 
 
 
13 (1.3%) 
[0.8, 2.3] 
 
51 (4.4%) 
[3.4, 5.8] 
 
 
49 (4.3%) 
[3.2, 5.6] 
- 
   Total - 9912 4140 9333 210 67 212  
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note: Female-only studies were not included in the total weighted prevalence figure. Flow chart interview (Faravelli, Degl' Innocenti, & Giardinelli, 1989); BDDQ = Body 
Dysmorphic Disorder Questionnaire (Phillips, 1996); BDDQ-Swedish Version (Brohede et al., 2013); DCQ = Dysmorphic Concern Questionnaire (Oosthuizen et al., 1998); 
SCID-I/P for DSM-IV = Structured Clinical Interview for DSM-IV patient version (First, Spitzer, Gibbon, & Williams, 1995b); DSM = Diagnostic and Statistical Manual for 
Mental Disorders – 4th edition (American Psychiatric Association, 1994), - 4th edition-revised (American Psychiatric Association, 2000), - 5th edition (American Psychiatric 
Association, 2013);  χ2 = Chi square statistic for likelihood ratio test comparing random vs. fixed effect model; Z = test of whether prevalence differs from 0; τ2 = between-
study variance of prevalence;  I2 = percentage of between study variance which is due to heterogeneity rather than chance;  ** p ≤ .001; *  p ≤ .05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Weighted prevalence      
1.9% 
[1.4, 2.7] 
1.6% 
[1.3, 2.1] 
2.1% 
[1.5, 2.9]  
       
Z 
χ2 
τ2 
I2 
-22.36** 
8.89** 
0.11 
55.0% 
-21.54** 
15.57** 
0.17 
61.4% 
-33.25** 
0.00 
0.00 
0.0% 
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Table 3.  
Prevalence of BDD in students 
Reference 
Location 
(Type of 
student) 
BDD screening 
tool Interview 
Age  
mean (SD) 
range 
Participants n (%) with BDD [CI (95%)] 
Total Male Female Total Male Female 
 
Bohne, 
Keuthen, et al. 
(2002) 
 
USA 
 
 
BDDQ 
 
 
No interview 
 
21.0  
(2.4) 
17-29 
 
 
 
101 
 
18 
 
83 
 
4  
(4.0%) 
[1.2, 10.1] 
 
2  
(11.1%) 
 [1.9, 34.1] 
 
2  
(2.4%) 
 [0.2, 8.9] 
Bohne, 
Wilhelm, et al. 
(2002) 
Germany 
(Psychology) 
 
BDDQ (German 
v.) 
 
No interview 22.0  
(3.5) 
19-37 
 
 
133 35 98 7  
(5.3%) 
[2.4, 10.7] 
2  
(5.7%) 
 [0.6, 19.6] 
5  
(5.1%) 
 [1.9, 11.7] 
Cansever et al. 
(2003) 
Turkey 
(Nursing) 
 
Items from the 
BDDE 
BDD-SCID for 
DSM-IV 
(Turkish v.) 
 
 
19.1  
(±1.0) 
17-23 
- - 420 
female 
only 
- - 20  
(4.8%) 
[3.1, 7.3] 
Sarwer et al. 
(2005) 
USA 
 
BDDQ No interview 20.5  
(±3.6) 
 
- 
 
 
- 559 
female 
only  
- - 14 
(2.5%) 
[1.5, 4.2] 
 
Bartsch (2007) Australia 
 
BDDQ 
DCQ 
No interview 26.1 
17-65 
619 169 450 14  
(2.3%) 
[1.3, 3.8] 
 
2  
(1.2%) 
 [0.1, 4.5] 
12  
(2.7%) 
 [1.5, 4.7] 
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note: no studies investigated prevalence of any other disorder in these patients. Female-only studies were not included in the total weighted prevalence figure. No information 
given about time period of prevalence figure.  
BDDQ = Body Dysmorphic Disorder Questionnaire (Phillips, 1996); BDDQ-German Version (Phillips et al., 1995); BDDE = Body Dysmorphic Disorder Evaluation 
(Rosen & Reiter, 1996); BDD-SCID for DSM-IV, Turkish version = Body Dysmorphic Disorder module of the Structured Clinical Interview for DSM-IV, Turkish version 
Taqui et al. 
(2008) 
Pakistan 
(Medicine) 
 
Adapted version 
of BIDQ for 
DSM-IV 
No interview Male: 20.8 
(±2.0) 
Female: 20.5 
(±1.8) 
 
 
156 67 89 9  
(5.8%) 
[2.9, 10.7] 
 
5 
(7.5%) 
 [2.9, 16.7] 
4 
(4.5%) 
 [1.4, 11.4] 
Boroughs et al. 
(2010) 
USA 
 
BDDE-SR 
 
 
No interview 21.0  
(4.2) 
18-56 
1041 344 697 51  
(4.9%) 
[3.7, 6.4] 
 
 
8  
(2.3%) 
[1.1, 4.6] 
43  
(6.2%) 
[4.6, 8.2] 
Liao et al. 
(2010) 
China 
(Medicine) 
 
BDDQ 
DCQ 
No interview 18.5  
(±0.8) 
16-21 
487 181 306 6  
(1.2%) 
[0.5, 2.7] 
0 
(0.0%) 
[0.0, 2.5] 
6  
(2.0%) 
[0.8, 4.3] 
 
   Total - 2537 814 2702 91 19 106 
   Weighted prevalence     
3.3% 
[2.0, 5.3] 
2.2% 
[0.7, 6.2] 
3.6% 
[2.6, 5.0] 
       
Z 
χ2 
τ2 
I2 
-13.42** 
8.87** 
0.23 
43.6% 
-19.19** 
6.25** 
0.11 
0.0% 
-6.82** 
4.89* 
1.09 
0.0% 
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(Corapcıoglu, Aydemir, Yildiz, Esen, & Koroglu, 1999); DCQ = Dysmorphic Concern Questionnaire (Oosthuizen et al., 1998); BDDE-SR = Body Dysmorphic Disorder 
Examination- Self Report version (Rosen & Reiter, 1995); BIDQ = Body Image Disturbance Questionnaire (Cash et al., 2004); BDD-SCID = Structured Clinical Interview 
for Body Dysmorphic Disorder (Phillips et al., 1995); DSM-IV = Diagnostic and Statistical Manual for Mental Disorders 4th Edition (American Psychiatric Association, 
1994); χ2 = Chi square statistic for likelihood ratio test comparing random vs. fixed effect model; Z = test of whether prevalence differs from 0; τ2 = between-study variance 
of prevalence;  I2 = percentage of between study variance which is due to heterogeneity rather than chance;  ** p ≤ .001;  * p ≤ .05. 
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Table 4. 
Prevalence of BDD in an adult psychiatric inpatient setting  
Reference 
Location 
(Recruitment 
period) 
BDD 
screening tool  Interview 
Participants n (%) with BDD [CI (95%)] Other disorders 
Total Male Female  Total Male Female 
 
Grant et 
al. (2001) 
 
USA 
*** 
 
BDDQ 
 
 
BDD-SCID 
for DSM-IV 
 
101 
 
50 
 
51 
 
13  
(12.9%) 
[7.5, 20.9] 
 
6  
(12.0%) 
[5.3, 24.2] 
 
 
7  
(13.7%)  
[6.5, 26.0] 
 
 
Psychotic dis: 20 (16.4%); mood 
dis: 92 (75.4%); substance use 
dis: 62 (50.8%); anxiety dis: 6 
(4.9%); somatoform: 1 (0.8%); 
EDs: 9 (7.4%); adjustment dis: 2 
(1.6%); impulse-control dis: 6 
(4.9%); ADHD: 2 (1.6%); other: 
5 (4.1%). 
 
 
Conroy et 
al. (2008) 
USA 
*** 
BDDQ 
Defect 
severity scale 
(1-5) 
 
 
BDD-SCID 
for DSM-IV 
(SCID-I/P, v. 
2.0) 
100 33 67 16  
(16.0%) 
[10.0,  24.5] 
5  
(15.2%) 
[6.2, 31.4] 
11  
(16.4%) 
[9.3, 27.2] 
Unipolar mood dis: 55.0%; 
bipolar dis: 21.0%; psychotic 
disorder: 15.0%; anxiety dis: 
3.0%; substance use dis: 2.0%; 
EDs: 2.0%; adjustment dis: 
1.0%; BPD: 1.0%. 
Kollei et 
al. (2011) 
Germany 
*** 
Psychiatrist-
rated defect 
severity scale 
(0-10) 
 
BDD-SCID 
for DSM-IV 
(German v.) 
155 60 95 3  
(1.9%) 
[0.4, 5.8] 
0  
(0.0%) 
[0.0, 6.0] 
 
3  
(3.2%) 
 [0.7, 9.3] 
Psychotic dis: 12 (7.7%); mood 
dis: 69 (44.5%); substance use 
dis: 16 (10.3%); anxiety dis: 25 
(16.1%); somatoform: 3 (1.9%); 
EDs: 14 (9.0%); PDs: 12 (7.7%); 
impulse-control dis: 1 (0.6%); 
ADHD: 1 (0.6%); other: 1 
(0.6%). 
 
 
Veale, 
Akyüz, et 
UK 
(13 month 
One screening 
question  
BDD-SCID-I 
for DSM-IV 
432 208 224 25  
(5.8%) 
9  
(4.3%) 
16 
(7.1%) 
Psychotic dis: 18 (4.2%); mood 
dis: 186 (43.0%); substance use 
dis: 162 (37.5%); anxiety dis: 49 
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note: *** = no information available about time period of prevalence.  
BDDQ = Body Dysmorphic Disorder Questionnaire (Phillips, 1996); BDD-SCID for DSM-IV -German Version (Wittchen, Wunderlich, Gruschwitz, & Zaudig, 1997); BDD-
SCID for DSM-IV = Body Dysmorphic Disorder module of the Structured Clinical Interview for DSM-IV (Phillips et al., 1995); SCID-I/P v 2.0 = Structured Clinical 
Interview for DSM-IV axis 1 disorder- Patient edition (First, Gibbon, & Spitzer, 1996); χ2 = Chi square statistic for likelihood ratio test comparing random vs. fixed effect 
model; Z = test of whether prevalence differs from 0; τ2 = between-study variance of prevalence;  I2 = percentage of between study variance which is due to heterogeneity 
rather than chance;  ** p ≤ .001; * p ≤ .05. 
 
 
 
 
 
 
 
 
 
al. (2015) period -
2013) 
[3.9, 8.4]  [2.2, 8.1]  [4.4, 11.4] (11.3%); eating dis: 2 (0.5%); 
adjustment dis: 8 (1.9%); 
personality dis: 4 (0.9%); other: 
3  
(0.7%). 
 
   Total 788 351 437 57 20 37  
   Weighted prevalence     
7.4% 
[3.5, 15.0] 
5.6% 
[2.0, 14.7] 
9.6% 
[4.9, 18.0]  
      
Z 
χ2 
τ2 
I2 
-6.22** 
10.99** 
0.55 
72.6% 
-6.10** 
5.21* 
0.40 
4.5% 
-5.22** 
3.14* 
0.77 
42.4% 
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Table 5. 
Prevalence of BDD in an adolescent psychiatric inpatient setting 
Reference Location  
BDD 
screening 
tool 
Interview 
Participants n (%) with BDD [CI (95%)] Other disorders  
Total Male Female  Total Male Female 
 
Grant et al. 
(2001) 
 
 
USA 
 
 
BDDQ 
 
BDD-
SCID for 
DSM-IV 
 
21 
 
7 
 
14 
 
3 (14.3%) 
[4.1, 35.5] 
 
0 (0.0%) 
[0.0, 40.4] 
 
3 (21.4%) 
[6.8, 48.3] 
 
- 
Dyl et al. 
(2006) 
USA 
 
BDDQ for 
adolescents 
No 
interview 
208 78 130 14 (6.7%) 
[4.0, 11.1] 
7 (9.0%) 
[4.2, 17.7] 
7 (5.4%) 
[2.4, 10.9] 
Bipolar: 84 (40.4%); 
MDD/Dysthymic: 82 (39.4%); 
Oppositional Defiant 
Disorder/Conduct Dis: 40 
(19.2%); PTSD/Acute Stress 
Dis: 32 (15.4%); Anxiety Dis: 
20 (9.6%); ADHD: 25 
(12.0%); Psychotic Dis: 7 
(3.4%); Other: 17 (8.2%). 
   Total 229 85 144 17 7 10  
   Weighted prevalence     
7.4% 
[4.7, 11.6] 
3.5% 
[1.1, 10.4] 
6.9% 
[3.8, 12.4]  
      
Z 
χ2 
τ2 
-10.01** 
- 
- 
-7.92** 
- 
- 
-5.63** 
- 
- 
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note: no information available about time period of prevalence. BDDQ = Body Dysmorphic Disorder Questionnaire (Phillips, 1996); BDD-SCID = Structured Clinical 
Interview for Body Dysmorphic Disorder (Phillips et al., 1995); χ2 = Chi square statistic for likelihood ratio test comparing random vs. fixed effect model; Z = test of 
whether prevalence differs from 0; τ2 = between-study variance of prevalence; ** p ≤ .001;  * p  ≤ .05. 
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Table 6.  
Prevalence of BDD in an adult psychiatric outpatient setting  
Reference 
Location 
(Recruitment 
period)  
BDD 
screening tool Interview 
Participants n (%) with BDD [CI (95%)] Other disorders  
Total 
(type)  Male Female  Total Male Female 
 
Wilhelm et 
al. (1997) 
 
USA 
*** 
 
- 
 
BDD-SCID-
OP for DSM-
IV 
 
165  
(anxiety 
disorder 
patients) 
 
81 
 
84 
 
11 (6.7%) 
[3.6, 11.7] 
 
4 (4.9%) 
 [1.6, 12.4] 
 
7 (8.3%) 
 [3.8, 16.5] 
 
Primary diagnoses: 
panic with/without 
agoraphobia (80) + 
BDD (3); OCD (40) 
+ BDD (3); social 
phobia (25) + BDD 
(3); GAD (20) + 
BDD (2) 
Zimmerman 
and Mattia 
(1998) 
USA 
*** 
PDSQ (self-
report 
questionnaire) 
BDD-SCID 
for DSM-IV 
500 
(general 
psychiatric 
outpatients) 
198 302 16 (3.2%) 
[1.9, 5.2] 
4 (2.0%) 
[0.6, 5.3] 
12 (4.0%) 
[2.2, 6.9] 
BDD = additional 
diagnosis for 13 
(2.6%): MDD (7), 
social phobia (1), 
panic disorder with 
agoraphobia (1), 
PTSD (1), dysthymic 
disorder (1), and 
eating and depressive 
disorder NOS (1 
each). 
Kelly et al. 
(2015) 
USA 
(Aug. 2009 - 
June 2011) 
BDDQ 
 Psychiatrist-
rated defect 
severity scale 
(1-5) 
BDD- SCID-
I/P for DSM-
IV: patient v. 
100 
(Veterans) 
94 6 11 (11.0%) 
[6.1, 18.8] 
9 (9.6%) 
 [4.9, 17.4] 
2 (33.3%) 
 [9.2, 70.4] 
Mood disorder or 
MDD, followed by 
substance use 
disorder = most 
common. 
   Total 765 373 392 38 17 21  
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note: *** =  no information given about time period of prevalence.  
PDSQ = the Psychiatric Diagnostic Screening Questionnaire (Zimmerman & Mattia, 2001); BDD-SCID for DSM-IV = Body Dysmorphic Disorder module of the Structured 
Clinical Interview for DSM-IV (First, Spitzer, Gibbon, Williams, & Benjamin, 1997) ; BDDQ = Body Dysmorphic Disorder Questionnaire (Phillips, 1996); SCID-I/P for 
DSM-IV = Structured Clinical Interview for DSM-IV patient version (First et al., 1995b);BDD-SCID-OP = Body Dysmorphic Disorder module of the Structured Clinical 
interview for DSM-IV- outpatient version (Spitzer, Williams, & Gibbon, 1988); χ2 = Chi square statistic for likelihood ratio test comparing random vs. fixed effect model; Z = 
test of whether prevalence differs from 0; τ2 = between-study variance of prevalence;  I2 = percentage of between study variance which is due to heterogeneity rather than 
chance;  **  p ≤ .001; * p ≤ .05. 
 
 
 
 
 
 
 
 
 
 
 
 
   Weighted prevalence    
5.8% 
[3.2, 10.4] 
4.6% 
[2.1, 9.7] 
6.5% 
[2.6, 15.6]  
      
Z 
χ2 
τ2 
I2 
-8.64** 
3.83** 
0.22 
47.7% 
-5.36** 
0.38 
0.17 
11.3% 
-7.39** 
2.26 
0.30 
0.0% 
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Table 7.  
Prevalence of BDD in general cosmetic surgery clinics 
Reference 
Location 
(Recruitment 
period) 
BDD 
screening 
tool 
Interview 
Participants n (%) with BDD [CI 95%] 
Most 
common 
procedures/ 
location of 
procedures 
sought  
Other 
disorders  
Total Male Female Total Male Female 
 
Ishigooka et 
al. (1998) 
 
Japan 
(Jan. 1980- 
June 1997) 
 
 
 
 
 
 
 
- 
 
Psychiatric 
interview 
using 
ICD-10 
criteria 
 
415 
 
130 
 
285 
 
64  
(15.4%) 
[12.3, 19.2] 
 
 
43  
(33.1%) 
[25.6, 41.6] 
 
19  
(6.7%) 
[4.3, 10.2] 
 
Facial surgeries 
 
Schizophrenia: 
17 (4.1%); 
depression: 33 
(8%); neurotic 
dis: 47 (11.3%); 
hypochondriacal 
dis: 42 (10.1%); 
paranoid PD: 5 
(1.2%); 
histrionic PD: 
14 (3.4%); 
other: 20 
(4.8%). 
 
 
Sarwer, 
Wadden, et 
al. (1998) 
USA 
*** 
BDDE-SR 
MBSRQ 
Surgeon-
rated 
defect 
severity 
scale  
 
 
No 
interview 
-   0 100 
female 
only  
- - 7  
(7.0%) 
[3.2, 14.0] 
face lift, 
blepharoplasty, 
breast reduction, 
rhinoplasty, 
liposuction 
- 
Altamura et 
al. (2001)  
Italy 
*** 
- BDD-
YBOCS 
478 114 364 30  
(6.3%) 
4  
(3.5%) 
26  
(7.1%) 
face, nose, 
genitals, hair, 
Mood dis: 69 
(14.4%); OCD: 
PREVALENCE OF BDD 67 
BDD-
SCID-I for 
DSM-IV 
[4.4, 8.9] [1.1, 9.0] [4.9, 10.3] legs, abdomen 60 (12.6%); 
somatoform dis: 
53 (11.1%); 
EDs: 42 (8.8%); 
social phobia: 
31 (6.5%). 
Vargel &  
Uluşahin 
(2001) 
Turkey 
*** 
MBSRQ 
SCL-90-R 
 
0.5hr 
interview 
by first 
author using 
DSM-IV 
criteria for 
BDD 
 
 
20 7 13 4  
(20.0%) 
[7.5, 42.2] 
2  
(28.6%) 
 [7.6, 64.8] 
2  
(15.4%) 
 [3.1, 43.5] 
rhinoplasty, 
facial surgery, 
otoplasty, 
abdomino- 
reconstruction, 
mammoplasty 
yes, but no 
prevalence 
given. 
Vindigni et 
al. (2002) 
Italy 
(Feb. - Dec. 
2001) 
BDDE SCID II for 
DSM-IV 
MINI 
(Italian v.) 
 
 
56 11 45 30  
(53.6%) 
[40.7, 66.0] 
5  
(45.5%) 
[21.3, 72.0] 
25  
(55.6%) 
[41.2, 69.1] 
septorhinoplasty yes, all axis I 
and II disorders, 
but prevalence 
only given for 
BDD group, i.e. 
comorbidities. 
Aouizerate 
et al. (2003) 
France 
*** 
Surgeon-
rated 
defect 
severity 
scale (1-4) 
 
 
MINI v. 4.4 
BDD-SCID 
II for DSM-
IV 
132 8 124 12  
(9.1%) 
[5.2, 15.4] 
2  
(25.0%) 
 [6.3, 59.9] 
10  
(8.1%) 
 [4.3, 14.4] 
skin, nose, 
breast, 
legs/knees 
yes, all axis I 
disorders, but 
prevalence only 
given for BDD 
group, i.e. 
comorbidities. 
Bellino et 
al. (2006) 
Italy 
(Oct. 2001 - 
July 2003) 
- BDD-
YBOCS 
BDD-SCID 
for DSM-IV 
(Italian v.) 
66 9 57 11  
(16.7%) 
[9.4, 27.6] 
3  
(33.3%) 
 [11.7, 64.9] 
8  
(14.0%) 
 [7.0, 25.6] 
blepharoplasty, 
liposuction, 
rhinoplasty, 
abdominoplasty, 
otoplasty 
Anxiety dis: 17 
(25.8%); mood 
dis: 10 (15.2%); 
also assessed for 
axis II disorders 
but no 
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 prevalence 
given. 
Pavan et al. 
(2006) 
Italy 
(Dec. 2003 - 
Oct. 2004) 
- MINI 5.0 
(Italian v.) 
 
 
27 4 23 10  
(37.0%) 
[21.5, 55.8] 
2  
(50.0%) 
[15.0, 85.0] 
8  
(34.8%) 
[18.7, 55.2] 
rhinoplasty, 
mammoplasty 
MDD = most 
common: 14 
(51.9%) 
Lai, Lee, 
Yeh, and 
Chen 
(2010) 
Taiwan 
(Jan. 2006 - 
Dec. 2008) 
- DSM-IV-
TR to 
diagnose 
BDD 
 
 
763 92 671 54  
(7.1%)  
[5.4, 9.1] 
7  
(7.6%) 
[3.5, 15.1] 
47  
(7.0%) 
[5.3, 9.2] 
blepharoplasty, 
scar revision, 
rhinoplasty, 
mammoplasty, 
facelift, 
liposuction 
-  
Veale, 
Naismith, et 
al. (2014) 
 
 
UK  
(Jan. 2010 - 
May 2012) 
 
 
 COPS-L 
BIQLI 
BDD-SCID 
for DSM-IV 
- 
 
0 49 
female 
only  
- - 9  
(18.4%) 
[9.8, 31.6] 
Labiaplasty only  - 
Dey et al. 
(2015) 
USA 
(March - 
June 2014) 
BDDQ 
Surgeon-
rated 
defect 
severity 
scale (1-5) 
BDD-SCID 
for DSM-
IV-TR 
234 77 157 18  
(7.7%) 
[4.9, 11.9] 
6  
(7.8%) 
[3.3, 16.3] 
12  
(7.6%) 
[4.3, 13.0] 
nose, skin, hair, 
chin, ears 
-  
   Total 2191 452 1888 238 74 173   
   Weighted prevalence    
13.2% 
[7.2, 22.9] 
15.3% 
[7.9, 27.3] 
10.9% 
[5.8, 19.7] 
 
 
      Z -5.51** -5.94** -4.57**   
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note: Female-only studies were not included in the total weighted prevalence figure.*** = no information given about time period of prevalence figure.  
 ICD-10 = International Classification of Diseases vs. 10 (World Health Organization, 1992); BDDE = Body Dysmorphic Disorder Evaluation (Rosen & Reiter, 
1996);BDDE-SR = Body Dysmorphic Disorder Evaluation- Self Report version (Rosen & Reiter, 1995); MBSRQ = Multidimensional body-self rating questionnaire (Brown, 
Cash, & Mikulka, 1990); BDD-YBOCS = Yale Brown Obsessive Compulsive Scale modified for Body Dysmorphic Disorder (Phillips et al., 1997); BDD-SCID = Body 
Dysmorphic Disorder module of the Structured Clinical Interview for DSM-IV (Phillips et al., 1995); SCID II 2.0 (Phillips, 1996); SCL-90-R (Turkish version) = Symptom 
Checklist Revised (Dag, 1991); DSM-IV (American Psychiatric Association, 1994), - 4th edition revised (American Psychiatric Association, 2000); BDD-SCID for DSM-IV 
(Italian Version) (Mazzi, Morosini, De Girolamo, Lussetti, & Guaraldi, 2000); BDD-SCID for DSM-IV-TR = Body Dysmorphic Disorder module of the Structured Clinical 
Interview for DSM-IV-TR (First, Spitzer, Gibbon, & Williams, 2002); MINI = International Neuropsychiatric Interview (Sheehan et al., 1998); MINI- Italian version (Rossi 
et al., 2004); COPS-L = Cosmetic Procedure Scale- Labiaplasty (Veale et al., 2013); BDDQ = Body Dysmorphic Disorder Questionnaire  (Phillips, 1996); χ2 = Chi square 
statistic for likelihood ratio test comparing random vs. fixed effect model; Z = test of whether prevalence differs from 0; τ2 = between-study variance of prevalence;  I2 = 
percentage of between study variance which is due to heterogeneity rather than chance;  ** p ≤ .001;  *  p ≤ .05. 
 
 
 
 
 
 
 
 
 
 
χ2 
τ2 
I2 
80.62** 
0.95 
90.0% 
82.07** 
1.22 
10.0% 
8.92* 
0.79 
87.8% 
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Table 8.  
Prevalence of BDD in those seeking Rhinoplasty surgery 
Reference 
Location 
(Recruitment 
period) 
BDD 
screening 
tool 
Interview 
Participants n (%) with BDD [CI 95%] Other disorders  
Total Male Female Total Male Female 
 
Veale, De 
Haro, et al. 
(2003) 
 
UK 
*** 
 
BDDQ 
Patient-rated 
nose 
imperfection 
scale (0-8) 
 
 
BDD-YBOCS 
 
29 
 
7 
 
22 
 
6 (20.7%) 
[9.5, 38.8] 
 
Missing 
 
 
Missing 
 
 
Anxiety & depression, but no 
prevalence given. 
Alavi et al. 
(2011) 
Iran 
(Aug. 2007 - 
Jan. 2008)  
- DSM IV-TR 
criteria for 
BDD used in 
interview 
 
 
306 61 245 75 (24.5%) 
[20.0, 29.6] 
Missing  Missing OCD: 63 (20.6%); AN: 3 
(1.0%); SAD: 4 (1.3%); 
somatic delusion: 4 (1.3%); 
gender identity disorder: 13 
(4.2%) 
Ghadakzadeh 
et al. (2011) 
Iran 
(Jan. 2008 - 
Sept. 2009)  
BICI-SR 
(Persian v.) 
Surgeon-
rated nose 
defect scale 
(1-2) 
 
 
Semi-
structured 
interview for 
BDD (DSM-
IV criteria). 
104 15 89 31 (29.8%) 
[21.8, 39.2] 
6 (40%) 
[19.8, 64.3] 
 
25 (28.1%) 
[19.8, 38.2] 
Those with other psych. 
disorders were excluded. 
Constantian 
(2012) 
USA 
(July 2007 - 
Oct. 2008) 
Surgeon-
rated nose 
deformity 
scale (1-5) 
DSM-IV 
Criteria 
150 29 121 3 (2.0%) 
[0.4, 6.0] 
1 (3.5%) 
[0.0, 18.6] 
2 (1.7%) 
[0.1, 6.2] 
Depression: 40 (26.7%) 
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Picavet et al. 
(2012) 
Belgium 
(April 2009 - 
Dec. 2010) 
Surgeon-
rated nasal 
deformity 
rating (0-25) 
BDD-YBOCS 
DSM IV-TR 
criteria for 
BDD 
 
 
166 71 95 3 (1.8%)  
[0.4, 5.4] 
 
Missing Missing  - 
Fathololoomi 
et al. (2013) 
Iran 
(Oct. 2010 - 
Oct. 2011) 
- Interviewed 
with 4-item 
BDD 
questionnaire 
 
 
130 31 99 41 (31.5%) 
[24.2, 40.0] 
8 (25.8%) 
 [13.5, 43.5] 
33 (33.3%) 
 [24.8, 43.1] 
Anxiety & depression, but 
prevalence only given for BDD 
group, i.e. comorbidities. 
Felix et al. 
(2014) 
Brazil 
(Sept. 2009 - 
Aug. 2010) 
BDDE 
(Brazilian-
Portuguese 
v.) 
Surgeon-
rated nasal 
defect scale 
(1-2) 
 
 
 
 
 
 
 
 
 
 
“Clinical 
interview 
assessing 
BDD” 
-  0 116 
female 
only 
- - 31 (26.7%) 
[19.5, 35.5] 
- 
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note: Female-only studies were not included in the total weighted prevalence figure. *** = no information given about time period of prevalence.    
BDDQ = Body Dysmorphic Disorder Questionnaire (Phillips, 1996); BDD-YBOCS = Yale Brown Obsessive Compulsive Disorder Scale modified for BDD (Phillips et al., 
1997); DSM-IV-TR = Diagnostic and Statistical Manual for Mental Disorders -  4th Edition revised (American Psychiatric Association, 2000), - 4th Edition (American 
Psychiatric Association, 1994); BICI-SR = Body Image Concern Inventory, self-report version (Littleton et al., 2005); SCID for DSM-IV = Semi structured Interview for 
DSM-IV (First et al., 1995a); BDDE-Brazilian-Portuguese Version = Body Dysmorphic Disorder Evaluation- Brazilian-Portuguese Version (Jorge et al., 2008); χ2 = Chi 
square statistic for likelihood ratio test comparing random vs. fixed effect model; Z = test of whether prevalence differs from 0; τ2 = between-study variance of prevalence;  
I2 = percentage of between study variance which is due to heterogeneity rather than chance;  ** p ≤ .001;  * p ≤ .05. 
 
 
 
 
 
 
 
 
 
 
 
 
   Total 885 214 787 246 15 91  
   Weighted prevalence    
20.1% 
[9.9, 36.7] 
18.4% 
[5.9, 44.8] 
16.7% 
[5.3, 41.7]  
      
Z 
χ2 
τ2 
I2 
-3.25** 
52.89** 
0.98 
90.5% 
-2.47** 
38.32** 
1.57 
41.1% 
-2.28* 
3.40* 
0.91 
92.2% 
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Table 9.  
Prevalence of BDD in those seeking Orthognathic surgery 
Reference 
Location 
(Recruitment 
period) 
BDD screening 
tool Interview 
Participants n (%) with BDD [CI 95%] Other 
disorders  
Total Male Female Total Male Female 
 
Vulink et 
al. (2008) 
 
Netherlands 
(Sept. 2005 - 
March 2007) 
 
Nine questions 
from BDDQ, 11 
from BDDE. 
Surgeon-rated 
defect severity 
scale (1-4) 
 
 
 
DSM-IV 
criteria for 
BDD 
 
160  
 
54 
 
106 
 
16 (10.0%) 
[6.2, 15.7] 
 
5 (9.3%) 
 [3.6, 20.3] 
 
11 (10.4%) 
 [5.7, 17.8] 
-  
Collins et 
al. (2014) 
USA 
(May 2010 - 
June 2013) 
BIDQ No interview 99 46 53 13 (13.1%) 
[7.7, 21.3] 
3 (6.5%) 
 [1.6, 18.2] 
10 (18.9%) 
 [10.4, 31.6] 
OCD: 29 (29.3%); 
MDD: 16 
(16.2%); anxiety: 
23 (23.2%). 
 
   Total 259 100 159 29 8 21  
   Weighted prevalence    
11.2% 
[7.9, 15.6] 
8.0% 
[4.1, 15.2] 
13.2% 
[8.8, 19.4]  
      
Z 
χ2  
τ2 
-10.51** 
- 
- 
-8.04** 
- 
- 
-6.63** 
- 
- 
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note: BDDQ = Body Dysmorphic Disorder Questionnaire (Phillips, 1996); BDDE = Body Dysmorphic Disorder Evaluation (Rosen & Reiter, 1996); DSM-IV = Diagnostic 
and Statistical Manual for Mental Disorders 4th Edition (American Psychiatric Association, 1994); BIDQ = Body Image Disturbance Questionnaire (Cash et al., 2004);  
χ2 = Chi square statistic for likelihood ratio test comparing random vs. fixed effect model; Z = test of whether prevalence differs from 0; τ2 = between-study variance of 
prevalence; **  p ≤ .001; * p ≤ .05. 
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Table 10.  
Prevalence of BDD in those seeking Orthodontics/Cosmetic dentistry  
Reference 
Location 
(Recruitment 
period) 
BDD screening tool Interview 
Participants n (%) with BDD [CI 95%] 
Total Male Female Total Male Female 
 
Hepburn and 
Cunningham 
(2006) 
 
UK 
*** 
 
- 
 
 
BDD-YBOCS 
Diagnosis 
confirmed by 
psychiatrist  
 
 
 
40  
 
16 
 
24 
 
3 (7.5%) 
[1.9, 20.6] 
 
1 (6.3%) 
 [0.0, 30.3] 
 
2 (8.3%) 
 [1.2, 27.0] 
de Jongh et al. 
(2009) 
Netherlands 
(May - Oct. 
2006) 
- DSM-IV-TR 
criteria for BDD 
 
 
170 64 106 7 (4.1%) 
[1.9, 8.4] 
Missing 
 
Missing 
 
Yassaei, Goldani-
Moghadam, 
Aghili, and 
Tabatabaei (2014) 
Iran 
(Oct. 2011 - 
Sept. 2012) 
BDD-YBOCS (self-
report 
questionnaire). 
Patients with 
obvious physical 
defects were 
excluded 
 
No interview 270 103 167 15 (5.6%) 
[3.3, 9.0] 
2 (1.9%) 
[0.1, 7.2] 
13 (7.8%) 
[4.5, 13.0] 
   Total 480 183 297 25 - - 
   Weighted prevalence    
5.2% 
[3.5, 7.6] 
2.5% 
[0.8, 7.5] 
7.9% 
[4.8, 12.6] 
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note: None of these studies assessed patients for any other disorder. *** = no information given about time period of prevalence.    
DSM-IV-TR = Diagnostic and Statistical Manual for Mental Disorders 4th Edition- Revised (American Psychiatric Association, 2000); BDD-YBOCS = Yale Brown 
Obsessive Compulsive Disorder Scale for Body Dysmorphic Disorder (Phillips et al., 1997); χ2 = Chi square statistic for likelihood ratio test comparing random vs. fixed 
effect model; Z = test of whether prevalence differs from 0; τ2 = between-study variance of prevalence; **  p ≤ .001;  *  p ≤ .05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
Z 
χ2 
τ2 
-14.13** 
0.00 
0.00 
-9.16** 
- 
- 
-6.25** 
- 
- 
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Table 11.  
Prevalence of BDD in general dermatology clinics 
Reference 
Location 
(Recruitment 
period) 
BDD screening tool Interview 
Participants n (%) with BDD [CI 95%] 
Total Male Female Total Male Female 
 
Phillips et al. 
(2000)  
 
USA 
*** 
 
BDDQ 
Dermatologist-rated 
defect severity scale 
(1-5) 
 
 
 
BDD-SCID for  
DSM-IV 
 
118 
 
35 
 
83 
 
17 (14.4%) 
[9.1, 22.0] 
 
Missing 
 
Missing 
Calderon et al. 
(2009) 
 
Chile 
(Dec. 2005 - 
Jan. 2006) 
BDDQ-DV No interview 281 
 
70 211 34 (12.1%) 
[8.8, 16.5] 
 
 
5 (7.1%) 
[2.7, 16.0] 
29 (13.7%) 
[9.7, 19.1] 
Hsu et al. 
(2009) 
Singapore 
*** 
BDDQ-DV No interview 198 48 150 58 (29.3%) 
[23.4, 36.0] 
 
 
19 (39.6%) 
[27.0, 53.7] 
39 (26.0%) 
[19.6, 33.6] 
Conrado et al. 
(2010) 
Brazil 
*** 
BDDQ-DV 
Psychiatrist-rated 
defect severity scale 
(1-5) 
 
  
BDD-SCID, I/P for 
DSM-IV 
150  
 
36 
 
114 
 
10 (6.7%)  
 [3.5, 12.0] 
3 (8.3%) 
[2.1, 22.6] 
7 (6.1%) 
[2.8, 12.4] 
Dogruk-Kacar 
et al. (2014) 
 
Turkey 
(Feb. & May 
2013) 
BDDQ-DV 
Dermatologist-rated 
defect severity scale 
(1-5)  
No interview 167  
 
40 
 
127 
 
7 (4.2%) 
[1.9, 8.6] 
3 (7.5%) 
[1.9, 20.6] 
4 (3.2%) 
[1.0, 8.1] 
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note: None of these studies assessed patients for any other disorder. *** = no information given about time period of prevalence.    
BDDQ = Body Dysmorphic Disorder Questionnaire (Phillips, 1996); BDD-SCID for DSM-IV = Body Dysmorphic Disorder module of the Structured Clinical Interview for 
DSM-IV (Phillips et al., 1995); BDDQ-DV = Body Dysmorphic Disorder Questionnaire- Dermatology Version (Dufresne et al., 2001); BDD SCID-I/P for DSM-IV = Body 
Dysmorphic Disorder module of the Structured Clinical Interview for DSM-IV, patient version (First et al., 1995b); χ2 = Chi square statistic for likelihood ratio test 
comparing random vs. fixed effect model; Z = test of whether prevalence differs from 0; τ2 = between-study variance of prevalence;  I2 = percentage of between study 
variance which is due to heterogeneity rather than chance;  ** p ≤ .001;  *  p ≤ .05. 
 
 
 
 
 
 
 
 
   Total 914 229 685 126 - - 
   Weighted prevalence    11.3% [6.0, 20.2] 
14.0% 
[6.0, 29.2] 
13.4% 
[8.0, 21.6] 
      
Z 
χ2  
τ2 
I2 
-5.90** 
40.98** 
0.54 
87.8% 
-6.31** 
11.24** 
0.28 
76.5% 
-3.82** 
12.78** 
0.69 
73.3% 
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Table 12.  
Prevalence of BDD in cosmetic dermatology clinics 
Reference 
Location 
(Recruitment 
period) 
BDD 
screening tool Interview 
Participants n (%) with BDD [CI 95%] 
Total Male Female Total Male Female 
Phillips et al. 
(2000) 
USA 
*** 
BDDQ 
Dermatologist-
rated defect 
severity scale 
(1-5) 
 
 
BDD-SCID for 
DSM-IV 
150 46 104 15 (10.0%) 
[6.1, 16.0] 
Missing Missing 
Dufresne et al. 
(2001) 
USA 
*** 
BDDQ-DV 
Dermatologist-
rated defect 
severity scale 
(1-5) 
 
 
BDD-SCID for 
DSM-IV 
46 10 36 7 (15.2%) 
[7.3, 28.5] 
Missing  Missing  
Castle et al. 
(2004) 
 
Australia 
(Sept.- Nov. 
2001) 
DCQ 
Surgeon-rated 
defect severity 
scale (0-8) 
 
 
BDD-SCID 
 
137 18 119 4 (2.9%) 
[0.9, 7.5] 
Missing Missing  
Conrado et al. 
(2010) 
Brazil 
*** 
BDDQ-DV 
Psychiatrist-
rated defect 
severity scale 
(1-5) 
BDD-SCID, I/P for 
DSM-IV 
150 14 136 21 (14.0%) 
[9.3, 20.5] 
1 (7.1%) 
[0.0, 33.5] 
20 (14.7%) 
[9.7, 21.7] 
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note: None of these studies assessed patients for any other disorder. *** = no information given about time period of prevalence.  
BDDQ = Body Dysmorphic Disorder Questionnaire (Phillips, 1996); BDDQ-DV = Body Dysmorphic Disorder Questionnaire- Dermatology Version (Dufresne et al., 2001); 
BDD SCID-I/P for DSM-IV = Body Dysmorphic Disorder module of the Structured Clinical Interview for DSM-IV, patient version (First et al., 1995b); DCQ = Dysmorphic 
Concern Questionnaire (Oosthuizen et al., 1998); χ2 = Chi square statistic for likelihood ratio test comparing random vs. fixed effect model; Z = test of whether prevalence 
differs from 0; τ2 = between-study variance of prevalence;  I2 = percentage of between study variance which is due to heterogeneity rather than chance; ** p ≤ .001; *  p ≤ 
.05. 
 
 
 
 
 
 
 
 
 
Dogruk-Kacar et 
al. (2014) 
 
Turkey 
(Feb. & May 
2013) 
BDDQ-DV 
Dermatologist-
rated defect 
severity scale 
(1-5)  
No interview 151 28 123 13 (8.6%) 
[5.0, 14.3] 
2 (7.1%) 
[0.9, 23.7] 
11 (8.9%) 
[4.9, 15.5] 
   Total 634 116 518 60 - - 
   Weighted prevalence    9.2% [5.9, 13.9]  
 
 
      
Z 
χ2  
τ2 
I2 
-9.49** 
3.17* 
0.18 
0.0% 
- 
- 
- 
- 
- 
- 
- 
- 
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Table 13.  
Prevalence of BDD in acne clinics 
note: BDD-SCID (Turkish v.) for DSM-IV = Turkish version of the Body Dysmorphic Disorder module of the Structured Clinical Interview for DSM-IV (Corapcıoglu et al., 
1999); BDDQ-DV = Body Dysmorphic Disorder Questionnaire- Dermatology Version (Dufresne et al., 2001); χ2 = Chi square statistic for likelihood ratio test comparing 
random vs. fixed effect model; Z = test of whether prevalence differs from 0; τ2 = between-study variance of prevalence; **  p ≤ .001;  *  p ≤ .05. 
Reference 
Location 
(Recruitment 
period) 
BDD screening 
tool Interview 
Participants n (%) with BDD [CI 95%] Other disorders 
Total Male Female Total Male Female 
 
Uzun et al. 
(2003) 
 
 
Turkey 
(Feb. 2000 – 
March 2001) 
 
Dermatologist-
rated acne 
severity scale  
(0-8) 
 
 
 
BDD-SCID 
for DSM-IV 
(Turkish v.) 
 
159 
 
82 
 
77 
 
14 (8.8%) 
[5.2, 14.3] 
 
8 (9.8%) 
[4.8, 18.3] 
 
6 (7.8%) 
[3.3, 16.3] 
 
Dysthymia: 9(5.7%); 
social phobia: 
12(7.5%); MDD: 
9(5.7%); GAD: 3 
(1.9%); somatization 
dis: 3(1.9%); OCD: 
3(1.9%) 
 
Bowe et al. 
(2007) 
 
USA 
(Winter & 
Spring 2006) 
BDDQ-DV 
Dermatologist-
rated acne 
severity scale  
(0-8) 
No interview 128 36 92 18 (14.1%) 
[9.0, 21.2] 
Missing Missing - 
   Total 287 118 169 32 - -  
   Weighted prevalence    
11.1% 
[8.0, 15.3] - - 
 
      
Z 
χ2 
τ2 
-11.07** 
- 
- 
- 
- 
- 
- 
- 
- 
 
